Covaxin safe, can be stored at 2-8°C: Lancet publishes phase 2 results

Covaxin, made by Hyderabad-based Bharat Biotech, has been declared "safe, immunogenic with no serious side effects" by Lancet, which has published its phase 2 results. "BBV152 can be stored at 2-8°C, which is compatible with the immunisation cold chain requirements of most countries," it added. It also said, "The evaluation of safety outcomes requires extensive phase 3 clinical trials."